Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Week in Review: Betta Pharma Enters $392 Million Deal for C4 Therapeutics’ NSCLC Drug

CANbridge Approved to Launch Pruritus Therapy for Alagille Syndrome in China

Connect Reports UC Therapy Offers Statistically Significant Improvement

Impact Sells Rights for Two PARP Inhibitors to Eikon Therapeutics

invoX Makes 2nd Investment in pHion, a Belfast mRNA Vaccine Company

ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China